Pathologic evaluation for antibody-mediated rejection: Prognostic vs diagnostic markers?

Journal of Heart and Lung Transplantation

Volumn 30, Issue 2, 2011, Pages 136-138

  Rodriguez, E Rene ^a   Tan, Carmela D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; CARDIAC GRAFT REJECTION; CELLULAR IMMUNITY; DISEASE MARKER; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; MORTALITY; NOTE; PREVALENCE; PRIORITY JOURNAL;

EID: 78650949127     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.09.014     Document Type: Editorial

References (27)

1. D.O. Taylor, J. Stehlik, and L.B. Edwards Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report2009 J Heart Lung Transplant 28 2009 1007 1022
2. M.P. Revelo, J. Stehlik, and D. Miller Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant 30 2011 144 150
3. A.G. Kfoury, M.E. Hammond, and G.L. Snow Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection J Heart Lung Transplant 28 2009 781 784
4. M. Fedrigo, A. Gambino, and F. Tona Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation 90 2010 791 798
5. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
6. E.F. Reed, A.J. Demetris, and E. Hammond Acute antibody-mediated rejection of cardiac transplants J Heart Lung Transplant 25 2006 153 159
7. P.J. Michaels, M.L. Espejo, and J. Kobashigawa Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transplant 22 2003 58 69
8. M.G. Crespo-Leiro, A. Veiga-Barreiro, and N. Domenech Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis Am J Transplant 5 2005 2560 2564
9. E.R. Rodriguez, D.V. Skojec, and C.D. Tan Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers Am J Transplant 5 2005 2778 2785
10. C.D. Tan, G.G. Sokos, and D.J. Pidwell Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection Am J Transplant 9 2009 2075 2084
11. E.K. Ho, G. Vlad, and A.I. Colovai Alloantibodies in heart transplantation Hum Immunol 70 2009 825 829
12. L.M. Kucirka, J.J. Maleszewski, and D.L. Segev Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies Cardiovasc Pathol 19 2010 99 105
13. E.N. Bonnaud, N.P. Lewis, and M.A. Masek Reliability and usefulness of immunofluorescence in heart transplantation J Heart Lung Transplant 14 1995 163 171
14. M.A. Lones, L.S. Czer, and A. Trento Clinicalpathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients J Heart Lung Transplant 14 1995 151 162
15. M.L. Rose, and J.D. Smith Clinical relevance of complement-fixing antibodies in cardiac transplantation Hum Immunol 70 2009 605 609
16. E.H. Hammond, R.L. Yowell, and S. Nunoda Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications J Heart Transplant 8 1989 430 443
17. A.G. Kfoury, D.G. Renlund, and G.L. Snow A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation J Heart Lung Transplant 28 2009 51 57
18. E.H. Hammond, J.K. Hansen, and L.S. Spencer Vascular rejection in cardiac transplantation: histologic, immunopathologic, and ultrastructural features Cardiovasc Pathol 2 1993 21 34
19. D.O. Taylor, R.L. Yowell, and A.G. Kfoury Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection J Heart Lung Transplant 19 2000 518 521
20. E.H. Hammond, R.L. Yowell, and G.D. Price Vascular rejection and its relationship to allograft coronary artery disease J Heart Lung Transplant 11 suppl 1992 S111 S119
21. E.H. Hammond, J.K. Hansen, and L.S. Spencer Immunofluorescence of endomyocardial biopsy specimens: methods and interpretation J Heart Lung Transplant 12 suppl 1993 S113 S124
22. M.E. Hammond, J. Stehlik, and G. Snow Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies J Heart Lung Transplant 24 2005 2015 2021
23. A.G. Kfoury, M.E. Hammond, and G.L. Snow Early screening for antibody-mediated rejection in heart transplant recipients J Heart Lung Transplant 26 2007 1264 1269
24. B. Sis, M. Mengel, and M. Haas Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups Am J Transplant 10 2010 464 471
25. S.K. Takemoto, A. Zeevi, and S. Feng National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1041
26. G.W. Wu, J.A. Kobashigawa, and M.C. Fishbein Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes J Heart Lung Transplant 28 2009 417 422
27. E.J. Lepin, Q. Zhang, and X. Zhang Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts Am J Transplant 6 2006 1560 1571